OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria
OpGen, Inc. today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antim…
OpGen, Inc. today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antim…
IGeneX is excited to announce the availability of their newly-developed, advanced testing methods t…
The US Food and Drug Administration (FDA) has approved a point-of-care influenza (flu) A & B 2 …
First Light Biosciences, a developer of breakthrough automated diagnostic products for rapid, sensi…
A team of scientists at Columbia University Mailman School of Public Health has developed a diagnos…
Use of the US Food and Drug Administration–approved Accelerate Pheno blood culture detection system…
CERTUS, innovators in food safety technologies, announces that its CERTUS System for accurate and r…
The use of an oral rapid HIV test facilitated by a certified health educator (CHE) can significantl…
GenePOC Inc., member of the Debiopharm Group, is proud to announce the approval by Health Canada an…
PathSensors’ cutting-edge CANARY based assays for the detection of Ralstonia spp. and Phytophthor…
Bruker Corporation announced that is has completed the acquisition of an 80% majority interest in H…
When you get sick, you want the right treatment fast. But certain infectious microbes are experts a…
The UK startup company Oxford Nanopore Technologies is speeding the discovery of pathogens with its…
Karius, a life sciences company transforming infectious disease diagnostics with genomics, along wi…
The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,072,309 to Dr. Do…